NUVASIVE PCM CERVICAL DISC SYSTEM

Prosthesis, Intervertebral Disc

FDA Premarket Approval P100012

This medical device has supplements. The device description/function or indication may have changed. Be sure to look at the supplements to get an up-to-date information on device changes. The labeling included below is the version at time of approval of the original pma or panel track supplement and may not represent the most recent labeling.

Pre-market Approval Supplement Details

Approval for the pcm cervical disc system. This device is indicated for use in skeletally mature patients for reconstruction of a degenerated cervical disc at one level from c3-c4 to c6-c7 following single-level discectomy for intractable radiculopathy (arm pain and/or a neurological deficit), with or without neck pain, or myelopathy due to a single-level abnormality localized to the disc space, and manifested by at least one of the following conditions confirmed by radiographic imaging(ct, mri, x-rays): herniated nucleus pulposus, spondylosis (defined by the presence of osteophytes), and/or visible loss of disc height as compared to adjacent levels. The pcm cervical disc is implanted using an anterior approach. Patients should have failed at least 6 weeks of conservative treatment prior to implantation of the pcm cervical disc.

DeviceNUVASIVE PCM CERVICAL DISC SYSTEM
Classification NameProsthesis, Intervertebral Disc
Generic NameProsthesis, Intervertebral Disc
ApplicantNUVASIVE, INC.
Date Received2010-04-01
Decision Date2012-10-26
Notice Date2012-11-08
PMAP100012
SupplementS
Product CodeMJO
Docket Number12M-1111
Advisory CommitteeOrthopedic
Expedited ReviewNo
Combination Product No
Applicant Address NUVASIVE, INC. 7475 Lusk Blvd san Diego, CA 92121
Summary:Summary of Safety and Effectiveness
Labeling: Labeling
Post-Approval Study:Show Report Schedule and Study Progress
Approval Order: Approval Order

Supplemental Filings

Supplement NumberDateSupplement Type
P100012Original Filing
S008 2018-05-03 Normal 180 Day Track No User Fee
S007
S006 2014-09-26 Normal 180 Day Track
S005 2013-12-18 Real-time Process
S004 2013-03-04 Normal 180 Day Track No User Fee
S003 2012-11-19 Normal 180 Day Track No User Fee
S002 2013-01-22 Special (immediate Track)
S001 2012-11-19 Normal 180 Day Track No User Fee

NIH GUDID Devices

Device IDPMASupp
00887517403438 P100012 000
00887517075970 P100012 000
00887517075987 P100012 000
00887517075994 P100012 000
00887517076502 P100012 000
00887517077349 P100012 000
00887517078537 P100012 000
00887517078544 P100012 000
00887517081124 P100012 000
00887517081131 P100012 000
00887517081148 P100012 000
00887517081155 P100012 000
00887517075963 P100012 000
00887517075956 P100012 000
00887517075949 P100012 000
00887517403445 P100012 000
00887517403452 P100012 000
00887517403469 P100012 000
00887517403476 P100012 000
00887517403483 P100012 000
00887517605184 P100012 000
00887517605191 P100012 000
00887517605207 P100012 000
00887517605214 P100012 000
00887517601148 P100012 000
00887517601155 P100012 000
00887517081162 P100012 000
00887517081179 P100012 000
00887517083555 P100012 000
00887517083562 P100012 000
00887517083579 P100012 000
00887517083593 P100012 000
00887517084002 P100012 000
00887517084019 P100012 000
00887517084026 P100012 000
00887517084033 P100012 000
00887517084040 P100012 000
00887517084057 P100012 000
00887517084064 P100012 000
00887517083166 P100012 000
00887517083159 P100012 000
00887517083142 P100012 000
00887517081186 P100012 000
00887517081193 P100012 000
00887517081605 P100012 000
00887517082565 P100012 000
00887517082572 P100012 000
00887517082589 P100012 000
00887517082596 P100012 000
00887517083104 P100012 000
00887517083111 P100012 000
00887517083128 P100012 000
00887517083135 P100012 000
00887517084071 P100012 000

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.